Potstock, good question. There are multiple articles which state the cost of Orphan drugs are in the hundreds of thousands per annum. I have only used 1 hundred thousand. As far as health care funds go, there is an article from thcare-economist which states that health plan seem to apply no restrictions to 70% of Orphan drug cost, have minor restrictions for 29% and don't respond to 1%.
However, above all of this are the discussions I have had with companies in this space. I am very comfortable with a 100k USD PA revenue assumption.
Ann: Notification of investor briefing webinar, page-31
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |